BAYLOR COLLEGE OF MEDICINE
Targeting TGFb In Osteogenesis Imperfecta
Targeting TGFb In Osteogenesis Imperfecta is a funding opportunity from BAYLOR COLLEGE OF MEDICINE, up to 594558, closing June 30, 2028.
Jun 30, 2028
(700d left)Overview
PROJECT SUMMARY Osteogenesis Imperfecta (OI) is a group of heterogeneous brittle bone disorders. Over 95% of patients harbor dominantly inherited structural mutations in the type I procollagen genes (COL1A1 and COL1A2) or recessively inherited mutations in the protein complexes important in type I collagen…